Global Medical Grade Chitosan Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Medical Grade Chitosan Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Chitosan (CS) is a linear polysaccharide which is achieved by deacetylation of chitin, which is the second most plentiful compound in nature, after cellulose. Chitosan was applied in pharmaceutics/drug/gene delivery and cell encapsulation. Chitosan was applied in binding to protein drugs, contact lenses and implants. GMP grade chitosan covers chitosan for a variety of medical applications.

According to our (Global Info Research) latest study, the global Medical Grade Chitosan market size was valued at US$ 37.9 million in 2023 and is forecast to a readjusted size of USD 63.1 million by 2030 with a CAGR of 7.6% during review period.

The industry"s leading producers are Primex, KitoZyme and BIO21, with a combined revenue share of 29.72% in 2019.

This report is a detailed and comprehensive analysis for global Medical Grade Chitosan market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Medical Grade Chitosan market size and forecasts, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Kg), 2019-2030

Global Medical Grade Chitosan market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Kg), 2019-2030

Global Medical Grade Chitosan market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Ton), and average selling prices (US$/Kg), 2019-2030

Global Medical Grade Chitosan market shares of main players, shipments in revenue ($ Million), sales quantity (Ton), and ASP (US$/Kg), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Medical Grade Chitosan

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Medical Grade Chitosan market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Primex, KitoZyme, BIO21, YSK, Vietnam Food, NovaMatrix, KIMICA, Ningbo Zhenhai Haixin Biological, Golden-Shell Pharmaceutical, Zhejiang Fengrun Biotech, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Medical Grade Chitosan market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Animal Origin Chitosan
Plant Based Chitosan

Market segment by Application
Wound Care
Healthcare Products
Antibacterial Products
Others

Major players covered
Primex
KitoZyme
BIO21
YSK
Vietnam Food
NovaMatrix
KIMICA
Ningbo Zhenhai Haixin Biological
Golden-Shell Pharmaceutical
Zhejiang Fengrun Biotech
Jiangsu Shuanglin
Jiangsu Aoxin Biotechnology
Qingdao Yunzhou Biochemistry

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Medical Grade Chitosan product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Medical Grade Chitosan, with price, sales quantity, revenue, and global market share of Medical Grade Chitosan from 2019 to 2024.

Chapter 3, the Medical Grade Chitosan competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Medical Grade Chitosan breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Medical Grade Chitosan market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Grade Chitosan.

Chapter 14 and 15, to describe Medical Grade Chitosan sales channel, distributors, customers, research findings and conclusion.